Patient Advocates In Research (PAIR), United States
This session will present current research and emerging best practices in the field of patient risk communication, including methods for collecting patient input in the design of these communication materials.
Learning Objective : Discover the likely triggers for a public hearing;
Analyse the relationship of public hearings to other parts of the global system
Understand how to prepare for a public hearing
Reflect on how to apply recognised principles of effective communication
Patient Engagement and Pharmacovigilance: Risk Interventions and Strategic Communications (RISC)
Emily Freeman, PhD, MSc
Director, Patient Centered Outcomes
AbbVie, Inc., United States
How Will EU Public Hearings Help with Patient and Public Engagement and How Should the Industry Prepare?
Shelley Gandhi, MS
NDA Group, United Kingdom
Can Patient-Generated Real-World Data Illuminate Real World Evidence of Safety Concerns Sooner Than Traditional Sources?
David Blaser, PharmD
Director, Health Informatics
PatientsLikeMe, United States
How Well Are We Doing Conveying Drug Safety Information to Patients? An Analysis of the Quality of REMS Educational Materials
Meredith Y. Smith, PhD, MPA
Global Risk Management Officer, Global Patient Safety
Amgen Inc., United States